New tools in therapeutic research-prostatic cancer and models

Toxicologic Pathology

Volumn 30, Issue 2, 2002, Pages 283-287

  Nyska, Abraham ^a   Dayan, Anthony ^b   Maronpot, Robert R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Retired Physician   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN DERIVATIVE; GROWTH FACTOR;

CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER MODEL; CANCER RESEARCH; CANCER RISK; ESTROGEN ACTIVITY; GENOMICS; METASTASIS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; PROTEOME; RATS;

EID: 0036216188     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262302753559623     Document Type: Review

References (42)

1. Hormones and diet: Low insulin-like growth factor-I but normal bioavailable androgens in vegan men
2. The association between polymorphisms in the CYP17 and 5-alpha-reductase (SRD5A2) genes and serum androgen concentrations in men
3. Animal models for the study of prostate carcinogenesis
4. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer
5. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol
6. Animal and tissue culture models of prostate cancer
7. Prostatic intraepithelial neoplasia: Animal models
8. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays
9. New developments in the analysis of gene expression
10. Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice
11. A reevaluation of non-hormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma
12. Cancer epigenetics takes center stage
13. Cellular and molecular pathology of prostate cancer precursors
14. Stem cells in prostatic epithelia
15. A transgenic mouse prostate cancer model
16. Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH(2)-terminal kinase
17. Optimal hormonal therapy for advanced prostate carcinoma
18. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone
19. A concise guide to cDNA microarray analysis
20. Neoplastic transformation of the prostate
21. Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats
22. Application of proteome analysis to the detection of "hepatoma-specific" serum proteins
23. Proteomics in human disease: Cancer, heart and infectious diseases
24. Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells
25. Proteomic profiling from human samples: The body fluid alternative
26. Tissue microarrays for high-throughput molecular profiling of tumor specimens
27. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats
28. Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: Attenuated effects in human 1321N1 astrocytoma cells
29. Work group I: Rodent models of prostate cancer
30. Pharmacogenetics, genomics, proteomics: The new frontiers in drug development
31. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
32. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties
33. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines
34. Drug development in prostate cancer
35. Background lesions and sectioning of male accessory sex organs in B6C3F1 mouse
36. A retrospective analysis of background lesions and tissue accountability for male accessory sex organs in Fischer-344 rats
37. Aberrant expression of hepatocyte growth factor and its receptor, c-met, during sex hormone-induced prostatic carcinogenesis in the Noble rat
38. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
39. The Dunning model
40. Use of nude mouse xenograft models in prostate cancer research
41. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells
42. Hormonal carcinogenesis of the Rb-knockout mouse prostate